In mouse models of RA and PsA, single-cell analysis of SFs showed that the number of CD200+ fibroblasts increases in synovial tissue following treatment with interleukin (IL)−17 inhibitors [59]. The gene discussed is CD200; the disease is rheumatoid arthritis.